Nucleic acid encoding eosinophil eotaxin receptor
OwnerBruce Daugherty, Julie Demartino +2inventors
InventorsBruce Daugherty, Julie Demartino, Salvatore Siciliano, Martin Springer
Life of this patent
Estimating the term…
Abstract
The eosinophil eotaxin receptor has been isolated, cloned and sequenced. This receptor is a human β-chemokine receptor and has been designated “CC CKR3”. The eosinophil eotaxin receptor may be used to screen and identify compounds that bind to the eosinophil eotaxin receptor. Such compounds would be useful in the treatment and prevention of atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and particularly bronchial asthma.
Claims15
1-35. (Canceled)
An isolated nucleic acid which encodes a human eosinophil eotaxin receptor receptor, said nucleic acid having the nucleotide sequence as set forth in SEQ ID NO:2.
A vector comprising a nucleic acid which encodes a human eosinophil eotaxin receptor receptor, said nucleic acid having the nucleotide sequence as set forth in SEQ ID NO:2.
A method to determine the presence of a compound which binds to a human eosinophil eotaxin receptor comprising:
- (a) introducing a nucleic acid which encodes the human eosinophil eotaxin receptor which comprises the nucleotide sequence (SEQ ID NO:2) into a cell under conditions so that eosinophil eotaxin receptor is expressed;
- (b) introducing a detector molecule or a nucleic acid encoding a detector molecule into the cell, wherein the detector molecule is directly or indirectly responsive to a eosinophil eotaxin-ligand binding event;
- (c) contacting the cell with a compound suspected of binding to the eosinophil eotaxin receptor;
- and
- (d) determining whether the compound binds to the eosinophil eotaxin receptor by monitoring the detector molecule.
Dependencies are inferred from the claim text.